This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Robert McCowan
Introduction
Robert McCowan is a notable inventor based in Katonah, NY (US). He has made significant contributions to the field of particle classification, particularly in the pharmaceutical industry. His work focuses on utilizing advanced machine learning techniques to enhance the analysis of fluids and samples.
Latest Patents
Robert McCowan holds a patent for "Methods and systems for particle classification." This patent describes methods that analyze a plurality of images of fluids and samples of pharmaceutical products, drugs, and medicines. The technology employs one or more machine learning models, including convolutional neural networks, to identify and classify sub-visible particles in each image. These particles may include cells, pathogens, protein aggregates, silicon oil droplets, fibers, air bubbles, glass particles, and combinations thereof.
Career Highlights
Throughout his career, Robert has worked with prominent companies such as Regeneron Pharmaceuticals, Inc. and Communications & Power Industries, Inc. His experience in these organizations has allowed him to develop and refine his innovative approaches to particle classification.
Collaborations
Robert has collaborated with talented individuals in his field, including Marco Hernandez and Aslam Nagarkatti. These partnerships have contributed to the advancement of his research and the successful implementation of his patented technologies.
Conclusion
Robert McCowan's innovative work in particle classification exemplifies the intersection of technology and pharmaceuticals. His contributions continue to impact the industry positively, showcasing the importance of machine learning in scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
